Lymphedema following breast cancer treatment, including sentinel lymph node biopsy
Identifieur interne : 000614 ( PascalFrancis/Corpus ); précédent : 000613; suivant : 000615Lymphedema following breast cancer treatment, including sentinel lymph node biopsy
Auteurs : J. Armer ; R. Fu ; J. M. Wainstock ; E. Zagar ; L. K. JacobsSource :
- Lymphology [ 0024-7766 ] ; 2004.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
To compare the occurrence, signs, and symptoms of lymphedema (LE) the arms of women after axillary lymph node dissection (ALND), sentinel lymph node biopsy (SLNB), combined SLNB and ALND (Both), or neither as part of breast cancer diagnosis and treatment, a concurrent descriptive-comparative cross-sectional four-group design with retrospective chart review was carried out. In a convenience sample of 102 women treated for breast cancer and receiving follow-up care at a midwestern United States cancer center, sequential circumferential measurements at five selected anatomical sites along both arms and hands were used to determine the presence of LE (≥2 cm differences between sites). Participants self-reported LE-related signs and symptoms by interview and completion of the Lymphedema and Breast Cancer Questionnaire (LBCQ). Retrospective chart review was carried out to verify lymph node-related diagnostic and treatment procedures. Based on node group, LE occurred as follows: 43.3% (29 of 67) of women who underwent ALND alone; 22.2% (2 of 9) of those who underwent SLNB alone; 25.0% (3 of 12) of those with combined SLNB and ALND; and 22.2% (2 of 9) with neither SLNB nor ALND. LE-related symptoms were reported by women who underwent ALND alone, SLND alone, combined SLNB and ALND, and neither. Among the node groups, three symptoms were more common: larger arm size, firmness/tightness in past year, and numbness in past year. We conclude that circumferential measurements of the upper arm and forearm may be critical for distinguishing LE from no LE. Overall, the proportion of women who experienced LE-related signs and symptoms was higher among women who underwent ALND versus SLNB. However, numbness and tenderness frequently were reported by those undergoing ALND, SLNB or both; and by women without LE. It is possible that some frequently occurring symptoms, such as numbness and tenderness, may be related to breast cancer surgery and not LE. Findings from this study can assist health professionals in educating women with breast cancer about LE risk factors, as well as early detection and management of LE by using the LBCQ and sequential circumferential arm measurements to evaluate limb changes subjectively and objectively concurrent with each breast cancer survivor's follow-up care.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 04-0600615 INIST |
|---|---|
| ET : | Lymphedema following breast cancer treatment, including sentinel lymph node biopsy |
| AU : | ARMER (J.); FU (R.); WAINSTOCK (J. M.); ZAGAR (E.); JACOBS (L. K.) |
| AF : | MU Sinclair School of Nursing, University of Missouri-Columbia/Columbia, Missouri/Etats-Unis (1 aut.); Ellis Fischel Cancer Center/Columbia, Missouri/Etats-Unis (1 aut., 3 aut., 4 aut., 5 aut.); Division of Nursing, New York University/New York/Etats-Unis (2 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Lymphology; ISSN 0024-7766; Coden LYMPBN; Etats-Unis; Da. 2004; Vol. 37; No. 2; Pp. 73-91; Bibl. 59 ref. |
| LA : | Anglais |
| EA : | To compare the occurrence, signs, and symptoms of lymphedema (LE) the arms of women after axillary lymph node dissection (ALND), sentinel lymph node biopsy (SLNB), combined SLNB and ALND (Both), or neither as part of breast cancer diagnosis and treatment, a concurrent descriptive-comparative cross-sectional four-group design with retrospective chart review was carried out. In a convenience sample of 102 women treated for breast cancer and receiving follow-up care at a midwestern United States cancer center, sequential circumferential measurements at five selected anatomical sites along both arms and hands were used to determine the presence of LE (≥2 cm differences between sites). Participants self-reported LE-related signs and symptoms by interview and completion of the Lymphedema and Breast Cancer Questionnaire (LBCQ). Retrospective chart review was carried out to verify lymph node-related diagnostic and treatment procedures. Based on node group, LE occurred as follows: 43.3% (29 of 67) of women who underwent ALND alone; 22.2% (2 of 9) of those who underwent SLNB alone; 25.0% (3 of 12) of those with combined SLNB and ALND; and 22.2% (2 of 9) with neither SLNB nor ALND. LE-related symptoms were reported by women who underwent ALND alone, SLND alone, combined SLNB and ALND, and neither. Among the node groups, three symptoms were more common: larger arm size, firmness/tightness in past year, and numbness in past year. We conclude that circumferential measurements of the upper arm and forearm may be critical for distinguishing LE from no LE. Overall, the proportion of women who experienced LE-related signs and symptoms was higher among women who underwent ALND versus SLNB. However, numbness and tenderness frequently were reported by those undergoing ALND, SLNB or both; and by women without LE. It is possible that some frequently occurring symptoms, such as numbness and tenderness, may be related to breast cancer surgery and not LE. Findings from this study can assist health professionals in educating women with breast cancer about LE risk factors, as well as early detection and management of LE by using the LBCQ and sequential circumferential arm measurements to evaluate limb changes subjectively and objectively concurrent with each breast cancer survivor's follow-up care. |
| CC : | 002B12B04; 002B26E; 002B25I |
| FD : | Appareil circulatoire pathologie; Traitement; Ganglion lymphatique; Lymphatique pathologie; Biopsie; Lymphoedème; Tumeur maligne; Cancer du sein |
| FG : | Glande mammaire pathologie |
| ED : | Cardiovascular disease; Treatment; Lymph node; Lymphatic vessel disease; Biopsy; Lymphedema; Malignant tumor; Breast cancer |
| EG : | Mammary gland diseases |
| SD : | Aparato circulatorio patología; Tratamiento; Ganglio linfático; Linfático patología; Biopsia; Linfedema; Tumor maligno; Cáncer del pecho |
| LO : | INIST-14604.354000114008510070 |
| ID : | 04-0600615 |
Links to Exploration step
Pascal:04-0600615Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Lymphedema following breast cancer treatment, including sentinel lymph node biopsy</title><author><name sortKey="Armer, J" sort="Armer, J" uniqKey="Armer J" first="J." last="Armer">J. Armer</name><affiliation><inist:fA14 i1="01"><s1>MU Sinclair School of Nursing, University of Missouri-Columbia</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Fu, R" sort="Fu, R" uniqKey="Fu R" first="R." last="Fu">R. Fu</name><affiliation><inist:fA14 i1="03"><s1>Division of Nursing, New York University</s1><s2>New York</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Wainstock, J M" sort="Wainstock, J M" uniqKey="Wainstock J" first="J. M." last="Wainstock">J. M. Wainstock</name><affiliation><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zagar, E" sort="Zagar, E" uniqKey="Zagar E" first="E." last="Zagar">E. Zagar</name><affiliation><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Jacobs, L K" sort="Jacobs, L K" uniqKey="Jacobs L" first="L. K." last="Jacobs">L. K. Jacobs</name><affiliation><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">04-0600615</idno><date when="2004">2004</date><idno type="stanalyst">PASCAL 04-0600615 INIST</idno><idno type="RBID">Pascal:04-0600615</idno><idno type="wicri:Area/PascalFrancis/Corpus">000614</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Lymphedema following breast cancer treatment, including sentinel lymph node biopsy</title><author><name sortKey="Armer, J" sort="Armer, J" uniqKey="Armer J" first="J." last="Armer">J. Armer</name><affiliation><inist:fA14 i1="01"><s1>MU Sinclair School of Nursing, University of Missouri-Columbia</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ></inist:fA14></affiliation><affiliation><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Fu, R" sort="Fu, R" uniqKey="Fu R" first="R." last="Fu">R. Fu</name><affiliation><inist:fA14 i1="03"><s1>Division of Nursing, New York University</s1><s2>New York</s2><s3>USA</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Wainstock, J M" sort="Wainstock, J M" uniqKey="Wainstock J" first="J. M." last="Wainstock">J. M. Wainstock</name><affiliation><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Zagar, E" sort="Zagar, E" uniqKey="Zagar E" first="E." last="Zagar">E. Zagar</name><affiliation><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Jacobs, L K" sort="Jacobs, L K" uniqKey="Jacobs L" first="L. K." last="Jacobs">L. K. Jacobs</name><affiliation><inist:fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Lymphology</title><title level="j" type="abbreviated">Lymphology</title><idno type="ISSN">0024-7766</idno><imprint><date when="2004">2004</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Lymphology</title><title level="j" type="abbreviated">Lymphology</title><idno type="ISSN">0024-7766</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biopsy</term><term>Breast cancer</term><term>Cardiovascular disease</term><term>Lymph node</term><term>Lymphatic vessel disease</term><term>Lymphedema</term><term>Malignant tumor</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Appareil circulatoire pathologie</term><term>Traitement</term><term>Ganglion lymphatique</term><term>Lymphatique pathologie</term><term>Biopsie</term><term>Lymphoedème</term><term>Tumeur maligne</term><term>Cancer du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To compare the occurrence, signs, and symptoms of lymphedema (LE) the arms of women after axillary lymph node dissection (ALND), sentinel lymph node biopsy (SLNB), combined SLNB and ALND (Both), or neither as part of breast cancer diagnosis and treatment, a concurrent descriptive-comparative cross-sectional four-group design with retrospective chart review was carried out. In a convenience sample of 102 women treated for breast cancer and receiving follow-up care at a midwestern United States cancer center, sequential circumferential measurements at five selected anatomical sites along both arms and hands were used to determine the presence of LE (≥2 cm differences between sites). Participants self-reported LE-related signs and symptoms by interview and completion of the Lymphedema and Breast Cancer Questionnaire (LBCQ). Retrospective chart review was carried out to verify lymph node-related diagnostic and treatment procedures. Based on node group, LE occurred as follows: 43.3% (29 of 67) of women who underwent ALND alone; 22.2% (2 of 9) of those who underwent SLNB alone; 25.0% (3 of 12) of those with combined SLNB and ALND; and 22.2% (2 of 9) with neither SLNB nor ALND. LE-related symptoms were reported by women who underwent ALND alone, SLND alone, combined SLNB and ALND, and neither. Among the node groups, three symptoms were more common: larger arm size, firmness/tightness in past year, and numbness in past year. We conclude that circumferential measurements of the upper arm and forearm may be critical for distinguishing LE from no LE. Overall, the proportion of women who experienced LE-related signs and symptoms was higher among women who underwent ALND versus SLNB. However, numbness and tenderness frequently were reported by those undergoing ALND, SLNB or both; and by women without LE. It is possible that some frequently occurring symptoms, such as numbness and tenderness, may be related to breast cancer surgery and not LE. Findings from this study can assist health professionals in educating women with breast cancer about LE risk factors, as well as early detection and management of LE by using the LBCQ and sequential circumferential arm measurements to evaluate limb changes subjectively and objectively concurrent with each breast cancer survivor's follow-up care.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0024-7766</s0></fA01><fA02 i1="01"><s0>LYMPBN</s0></fA02><fA03 i2="1"><s0>Lymphology</s0></fA03><fA05><s2>37</s2></fA05><fA06><s2>2</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Lymphedema following breast cancer treatment, including sentinel lymph node biopsy</s1></fA08><fA11 i1="01" i2="1"><s1>ARMER (J.)</s1></fA11><fA11 i1="02" i2="1"><s1>FU (R.)</s1></fA11><fA11 i1="03" i2="1"><s1>WAINSTOCK (J. M.)</s1></fA11><fA11 i1="04" i2="1"><s1>ZAGAR (E.)</s1></fA11><fA11 i1="05" i2="1"><s1>JACOBS (L. K.)</s1></fA11><fA14 i1="01"><s1>MU Sinclair School of Nursing, University of Missouri-Columbia</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ></fA14><fA14 i1="02"><s1>Ellis Fischel Cancer Center</s1><s2>Columbia, Missouri</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>3 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></fA14><fA14 i1="03"><s1>Division of Nursing, New York University</s1><s2>New York</s2><s3>USA</s3><sZ>2 aut.</sZ></fA14><fA20><s1>73-91</s1></fA20><fA21><s1>2004</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>14604</s2><s5>354000114008510070</s5></fA43><fA44><s0>0000</s0><s1>© 2004 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>59 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>04-0600615</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Lymphology</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>To compare the occurrence, signs, and symptoms of lymphedema (LE) the arms of women after axillary lymph node dissection (ALND), sentinel lymph node biopsy (SLNB), combined SLNB and ALND (Both), or neither as part of breast cancer diagnosis and treatment, a concurrent descriptive-comparative cross-sectional four-group design with retrospective chart review was carried out. In a convenience sample of 102 women treated for breast cancer and receiving follow-up care at a midwestern United States cancer center, sequential circumferential measurements at five selected anatomical sites along both arms and hands were used to determine the presence of LE (≥2 cm differences between sites). Participants self-reported LE-related signs and symptoms by interview and completion of the Lymphedema and Breast Cancer Questionnaire (LBCQ). Retrospective chart review was carried out to verify lymph node-related diagnostic and treatment procedures. Based on node group, LE occurred as follows: 43.3% (29 of 67) of women who underwent ALND alone; 22.2% (2 of 9) of those who underwent SLNB alone; 25.0% (3 of 12) of those with combined SLNB and ALND; and 22.2% (2 of 9) with neither SLNB nor ALND. LE-related symptoms were reported by women who underwent ALND alone, SLND alone, combined SLNB and ALND, and neither. Among the node groups, three symptoms were more common: larger arm size, firmness/tightness in past year, and numbness in past year. We conclude that circumferential measurements of the upper arm and forearm may be critical for distinguishing LE from no LE. Overall, the proportion of women who experienced LE-related signs and symptoms was higher among women who underwent ALND versus SLNB. However, numbness and tenderness frequently were reported by those undergoing ALND, SLNB or both; and by women without LE. It is possible that some frequently occurring symptoms, such as numbness and tenderness, may be related to breast cancer surgery and not LE. Findings from this study can assist health professionals in educating women with breast cancer about LE risk factors, as well as early detection and management of LE by using the LBCQ and sequential circumferential arm measurements to evaluate limb changes subjectively and objectively concurrent with each breast cancer survivor's follow-up care.</s0></fC01><fC02 i1="01" i2="X"><s0>002B12B04</s0></fC02><fC02 i1="02" i2="X"><s0>002B26E</s0></fC02><fC02 i1="03" i2="X"><s0>002B25I</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Traitement</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Treatment</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Tratamiento</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Ganglion lymphatique</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Lymph node</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Ganglio linfático</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Lymphatique pathologie</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Linfático patología</s0><s5>04</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Biopsie</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Biopsy</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Biopsia</s0><s5>05</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Lymphoedème</s0><s5>07</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Lymphedema</s0><s5>07</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Linfedema</s0><s5>07</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Tumeur maligne</s0><s5>10</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Malignant tumor</s0><s5>10</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Tumor maligno</s0><s5>10</s5></fC03><fC03 i1="08" i2="X" l="FRE"><s0>Cancer du sein</s0><s4>CD</s4><s5>96</s5></fC03><fC03 i1="08" i2="X" l="ENG"><s0>Breast cancer</s0><s4>CD</s4><s5>96</s5></fC03><fC03 i1="08" i2="X" l="SPA"><s0>Cáncer del pecho</s0><s4>CD</s4><s5>96</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Glande mammaire pathologie</s0><s2>NM</s2><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Mammary gland diseases</s0><s2>NM</s2><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Glándula mamaria patología</s0><s2>NM</s2><s5>37</s5></fC07><fN21><s1>348</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 04-0600615 INIST</NO><ET>Lymphedema following breast cancer treatment, including sentinel lymph node biopsy</ET><AU>ARMER (J.); FU (R.); WAINSTOCK (J. M.); ZAGAR (E.); JACOBS (L. K.)</AU><AF>MU Sinclair School of Nursing, University of Missouri-Columbia/Columbia, Missouri/Etats-Unis (1 aut.); Ellis Fischel Cancer Center/Columbia, Missouri/Etats-Unis (1 aut., 3 aut., 4 aut., 5 aut.); Division of Nursing, New York University/New York/Etats-Unis (2 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Lymphology; ISSN 0024-7766; Coden LYMPBN; Etats-Unis; Da. 2004; Vol. 37; No. 2; Pp. 73-91; Bibl. 59 ref.</SO><LA>Anglais</LA><EA>To compare the occurrence, signs, and symptoms of lymphedema (LE) the arms of women after axillary lymph node dissection (ALND), sentinel lymph node biopsy (SLNB), combined SLNB and ALND (Both), or neither as part of breast cancer diagnosis and treatment, a concurrent descriptive-comparative cross-sectional four-group design with retrospective chart review was carried out. In a convenience sample of 102 women treated for breast cancer and receiving follow-up care at a midwestern United States cancer center, sequential circumferential measurements at five selected anatomical sites along both arms and hands were used to determine the presence of LE (≥2 cm differences between sites). Participants self-reported LE-related signs and symptoms by interview and completion of the Lymphedema and Breast Cancer Questionnaire (LBCQ). Retrospective chart review was carried out to verify lymph node-related diagnostic and treatment procedures. Based on node group, LE occurred as follows: 43.3% (29 of 67) of women who underwent ALND alone; 22.2% (2 of 9) of those who underwent SLNB alone; 25.0% (3 of 12) of those with combined SLNB and ALND; and 22.2% (2 of 9) with neither SLNB nor ALND. LE-related symptoms were reported by women who underwent ALND alone, SLND alone, combined SLNB and ALND, and neither. Among the node groups, three symptoms were more common: larger arm size, firmness/tightness in past year, and numbness in past year. We conclude that circumferential measurements of the upper arm and forearm may be critical for distinguishing LE from no LE. Overall, the proportion of women who experienced LE-related signs and symptoms was higher among women who underwent ALND versus SLNB. However, numbness and tenderness frequently were reported by those undergoing ALND, SLNB or both; and by women without LE. It is possible that some frequently occurring symptoms, such as numbness and tenderness, may be related to breast cancer surgery and not LE. Findings from this study can assist health professionals in educating women with breast cancer about LE risk factors, as well as early detection and management of LE by using the LBCQ and sequential circumferential arm measurements to evaluate limb changes subjectively and objectively concurrent with each breast cancer survivor's follow-up care.</EA><CC>002B12B04; 002B26E; 002B25I</CC><FD>Appareil circulatoire pathologie; Traitement; Ganglion lymphatique; Lymphatique pathologie; Biopsie; Lymphoedème; Tumeur maligne; Cancer du sein</FD><FG>Glande mammaire pathologie</FG><ED>Cardiovascular disease; Treatment; Lymph node; Lymphatic vessel disease; Biopsy; Lymphedema; Malignant tumor; Breast cancer</ED><EG>Mammary gland diseases</EG><SD>Aparato circulatorio patología; Tratamiento; Ganglio linfático; Linfático patología; Biopsia; Linfedema; Tumor maligno; Cáncer del pecho</SD><LO>INIST-14604.354000114008510070</LO><ID>04-0600615</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000614 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000614 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:04-0600615
|texte= Lymphedema following breast cancer treatment, including sentinel lymph node biopsy
}}
| This area was generated with Dilib version V0.6.31. |  |